Plans to transform Oxfam HQ into lab space
Plans have been submitted to turn Oxfam's headquarters into an office and lab space.
GreyArc Investments Limited have applied to Oxford City Council for planning permission to turn the building on John Smith Drive, Oxford Business Park, Cowley into a life science or office facility and "create a significant number of job opportunities".
The charity said it had signed the lease for a new workplace within the ground floor of a smaller building on the same site, to help reduce costs.
Councillor Saj Malik, who represents Temple Cowley on the city council, has raised concerns about the knock-on effect of creating new science and tech jobs on the city's housing shortage.
Oxfam's HQ moved to Oxford Business Park from Summertown in July 2005, and the building was sold to Sutton Council in 2016.
It was put on the market for £60m in 2023 and sold to a private investor for £37.1m in April 2024.
Oxfam's lease on the building ran out in March.
Plans for the move include adding an extra floor to the building, as well as a gym and café area on the ground floor and a row of columns outside the building.
This comes after the charity announced it was trying to save £10.2m in wages, and that 265 jobs were at risk of redundancy.
According to the planning statement the proposal will "create a significant number of new job opportunities" and the plans would "positively contribute to Oxford's role as a leading hub for research and development and life sciences within the UK".
It adds the building could be used by multiple tenants and connectivity to the business park would be improved by upcoming plans for the Cowley Branch Line.
But Mr Malik said many Cowley residents felt "it's too much, too quickly and gentrification is being imposed on communities without thought of the impact".
"While I fully encourage investment into Cowley, this kind of development often doesn't benefit the people who live here in terms of job opportunities," he said.
"Already we have a shortage of housing in Oxford meaning teachers and nurses have to live elsewhere causing recruitment and retention difficulties."
A spokesperson for Oxfam said they hope to move in July.
"The new office space is smaller and will support us to reduce our costs," they added.
You can follow BBC Oxfordshire on Facebook, X (Twitter), or Instagram.
Charity shop donated guitars fetch £12,000 at auction
Oxfam GB puts 265 jobs at risk of redundancy
Charity shop 'shocked' as Bible sells for £56,000
Charity volunteers write next chapter for bookshop
Charity calls for second-hand festive party shopping
Oxfam
Oxford City Council
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
2 hours ago
- Associated Press
Chelsea signs striker Liam Delap from relegated Ipswich
LONDON (AP) — Chelsea signed striker Liam Delap from relegated Ipswich on Wednesday in time to play at the Club World Cup after activating his release clause of 30 million pounds ($40 million). Chelsea used the opening of a special trading window from June 1-10 to add a center forward to its squad, with the 22-year-old Delap set to provide competition for first-choice striker Nicolas Jackson. He signed a contract to keep him at Stamford Bridge until 2031. Delap scored 12 league goals — representing one-third of Ipswich's topflight total last season — and joins a resurgent Chelsea team that finished fourth in the Premier League and won the third-tier Conference League title. Delap, who left Manchester City to join Ipswich in last year's offseason, was also reportedly interesting Manchester United. Delap has played for England through the youth age grades but not yet for the senior team. ___ AP soccer:
Forbes
3 hours ago
- Forbes
The World's Best Vodka- According To The 2025 International Wine And Spirit Competition
The vodkas that won Gold Outstanding medals at the 2025 IWSC. Sophia Lindenberger Vodka may be the most under appreciated spirt in the world. Yes, it routinely tops the charts in sales across the globe, but it's the gins, whiskeys, tequilas and rums of the world that hog all the headlines. That is due to vodka's misunderstood nature; most people think it is a neutral spirit or an invisible mixer. They couldn't be further from the truth. These days, there is a wide array of premium vodkas in the market that showcase subtle mouthfeel and flavor derived from their diverse base ingredients, such as rye's spice, wheat's creaminess, potato's richness, or sugar beet's sweetness. Nowhere is this more on display than in the recently announced Gold Outstanding medal winners from the 2025 International Wine and Spirits Competition (IWSC). For over half a century, the IWSC has been running alcoholic beverages (over 12,000 this year) through its rigorous blind judging panels to discern the world's best bottles. They just awarded 10 Gold Outstanding medals in the vodka category. To qualify, each medal winner had to score a minimum of 98 out of 100 points in judging. Each of the winners is in the running for the IWSC's Vodka Trophy that will be awarded in November. Here is a brief recap of each winner and the judge's notes. Witchmark Distillery's Single Origin English Vodka is crafted by a young whisky distiller in Norfolk, England. While none of their whiskies are ready for release yet, their vodka and gin are quickly garnering fans; one can only imagine what their aged whiskies will deliver when they are released. Distilled from local barley, it has a creamy, rounded profile, lending it exceptional smoothness and versatility. Witchmark's commitment to controlling the entire process from raw ingredient to finished spirit ensures a pure and clean expression. It's a compelling choice for those seeking an authentic, high-quality English spirit. Here is what the judges had to say: The rich and malty nose entrances, with cocoa-studded dough inviting curiosity. The palate reveals a delightful combination of mint and toffee apple. The finish is pleasantly warming, leaving a luscious, oily texture that lingers. From Iceland's Eimverk Distillery, Iceland's first whisky maker, comes Kría Single Grain Vodka, a truly unique spirit born from its pristine environment. This vodka is made from locally grown Kría barley, used to craft their whiskies, and benefits from the island's pure, naturally filtered spring water. It's a distinct offering that has not been released to the public yet, though their showing at the IWSC should soon change that. Here is what the judges had to say: A fragrant embrace of baked sesame pastry and sweet cream cheese greets the senses, leading to a sumptuous palate of toffee, baked apple, and anise, all wrapped in a silky texture. The finish reveals a rich tapestry of honey and grain, leaving a lasting impression. Adnams, a 150-year-old brewery and distillery in Southwold, England, has some serious credentials behind its Longshore Triple Malt Vodka. It has twice won the Vodka Trophy at the IWSC. Unlike typical vodkas, this is distilled from a distinctive blend of East Anglican barley, wheat, and oats, imparting a truly unique character. You'll find a notably creamy texture, with inviting notes of oat and butterscotch, alongside a natural sweetness from the malted grains. It's known for its remarkable smoothness and approachable complexity, proving that vodka can offer more than just neutrality. Here is what the judges had to say: Invitingly creamy with delicate floral notes. The palate offers a luscious berry mouthfeel intertwined with strawberry, raisins, and a touch of maple syrup. Soft, peppery finish reminiscent of apple pie and a whisper of vanilla marzipan. Delightful. Belvedere Vodka helped launch the premium vodka category in the late 20th century with its distinctive Polish offerings. Their super-premium 10 Vodka is the pinnacle product for the brand. Crafted from a single, prized harvest of Dankowskie Diamond Rye, the "10" signifies the ten stages of vodka creation and the year the distillery was founded 1910. This meticulous process yields an exceptionally smooth and crisp vodka that is far from neutral. First released in 2023, it's designed for those who appreciate ultimate purity and a complex, highly refined sipping experience, setting a new benchmark for luxury vodka. Here is what the judges had to say: Aromas of rich caramel and a whisper of spice. Silky textured palate with a robust peppery character, complemented by creamy vanilla, sourdough notes and delicate florals. Warm, zesty finish that is both silky and long-lasting. Well-balanced with a fantastic profile. Laplandia, a company owned by a family of entrepreneurs, was founded in 2009 to craft exceptional spirits in the Finnish northern wilderness region of Lapland. By using the pure artesian waters of the area combined with wheat from family-owned farms, they can produce strikingly clean vodkas. Bilberry Vodka is a flavored vodka infused with bilberry, a wild blueberry native to Arctic regions, lending a unique sweet-tart berry profile that stands apart from common blueberry flavors. It's a compelling choice for those seeking an authentic and vibrant fruit-flavored vodka experience. Here is what the judges had to say: Vibrant fruity nose underscored by creamy undertones. The palate reveals a delightful interplay of wild blueberries and sour cherries, harmoniously balanced with sweet vanilla and luscious berry jam. Refreshing, juicy brightness to finish, accented by a hint of bitterness. Outstanding. For their second award-winning vodka, Laplandia used another local ingredient to craft a great sip. Its Cloudberry Vodka is infused with the rare and prized cloudberry, a golden-orange fruit found in Arctic climates, known for its unique sweet, subtly tart, and intensely aromatic taste. Like other Laplandia expressions, it benefits from a premium grain spirit base and pristine Arctic spring water. It's a distinctive choice for those seeking a unique, natural berry flavor that captures the wild essence of the Nordic North. Here is what the judges had to say: A delightful burst of orange marmalade and caramel layered with hints of peach and apricot. The palate reveals a captivating sweetness complemented by clove and honey, while a subtle touch of white pepper and dry, root notes linger beautifully. Hawkridge Distillers, a seven-year-old distiller based in England's Berkshire County, collaborated with London's acclaimed Sexy Fish restaurant to produce this distinctive vodka. Crafted likely as a house pour or signature spirit for the high-end establishment, it emphasizes exceptional smoothness and purity. While specific botanical details are often private for such collaborations, the focus is on a refined, neutral, or subtly nuanced profile that excels in sophisticated cocktail creations. It's a vodka that should highlight its three founders, all distillers, skill in crafting memorable bottles. Here is what the judges had to say: The aroma presents a delicate blend of floral and fruity notes, beautifully enhanced by a touch of peppery spice and sweet icing sugar. The profoundly deep palate resonates with creamy hints of smooth vanilla and lusciously crisp citrus. If you have never heard of Eckerts Wacholder Brennerei GmbH, don't feel bad; it's doubtful many people have. Located in the Saarland region of Germany, adjacent to Luxembourg and France, it is a 125-year-old distiller with a minimal footprint. They make a wide array of small-batch whiskeys that are sold in the region. Their vodka is an experimental product that they only serve onsite. They must be doing something right since they took home two GO medals at the IWSC. Here is what the judges had to say: Light minerality and creamy vanilla on the nose. The palate bursts with a harmonious blend of woodiness and grassiness, enriched by caramel undertones, hints of stone fruit, and vibrant orange marmalade. A luscious mouthfeel leads to a clean, refreshing finish. This is another winner from Germany's Eckerts Wacholder Brennerei GmbH. As stated before, there is not much known about this distillery; it is distinctly local. Korol Black Vodka is another experimental product available only onsite. One thing is for certain, though. If you find yourself visiting the Saarland region of Germany, you should search for this distillery. With 125 years of experience, they seem to be making some great spirits. Here is what the judges had to say: A delightful bouquet of sweet wheat leads to a palate revealing delightful notes of bittersweet cereal wrapped in creamy icing sugar. Boasts a rounded, uplifting finish, where warm spice lingers beautifully on the tongue. Absolut Hunni, a brand-new product from Sweden's iconic Absolut Vodka, is currently only available in England, but hopefully, that will change soon. A naturally flavored vodka, it is crafted using Swedish winter wheat and natural honey flavorings to deliver a sweet, smooth sip. Like all Absolut vodkas, it benefits from a continuous distillation process, ensuring consistent quality and purity without added sugars. It is a super-premium flavored vodka that could change the conversations around the flavored vodka category as distillers look to deliver more natural products to consumers. Here is what the judges had to say: Delightful aromas of fresh Acacia honey, complemented by distinctive floral notes. On the palate, sweet heather honey shines through, intermingled with a lingering peppery warmth and gorgeous hints of fresh honeycomb. Follow here for the most up to date information about the ever changing beer, wine, and spirits industry.
Medscape
3 hours ago
- Medscape
Thousands Missing Out on Life-Saving Heart Treatments
MANCHESTER — Thousands of people in the United Kingdom with advanced heart failure are not being referred for potentially life-saving treatments, a leading heart transplantation expert said at the British Cardiovascular Society Annual Conference 2025. Owais Dar Owais Dar, a consultant cardiologist at Harefield Hospital, Guy's and St Thomas' NHS Foundation Trust, London, described a 'systemic failure' in delivering transplants and left ventricular assist devices (LVADs) to eligible patients in the UK. This failure was leading to a 'deadly delay' in care, he said. Presenting data from a National Advanced Heart Failure Audit, Dar estimated that 10,000 adults under 65 who could be eligible for a heart transplant or LVAD therapy had not been referred to specialist services. Furthermore, 130,000 adults with advanced heart failure were living with palliative care needs. 'If this was a cancer, we would be furious about this,' said Dar, who is also an honorary senior lecturer at King's College London. 'We've got young people here who are not accessing [these therapies].' Dar noted wide variation in referral patterns. Even in regions with the highest rates of referral, the numbers fell short of what was needed. 'Generally, within the UK and Ireland, we're just not thinking about transplant or LVAD therapy as even an option,' he said. Specialist Services at Risk of Being Overwhelmed Geraint Jenkins, a consultant cardiologist at Morriston Hospital in Swansea, Wales, told Medscape News UK : 'The majority of the patients these days — because medical therapy is so good — get better.' He observed that half of patients with an ejection fraction under 30% regain nearly normal heart function within a year, 'and they don't get anywhere near a transplant centre'. Jenkins warned that current referral criteria were 'lax' and, if followed, could overwhelm specialist services. 'We've got thousands of patients with ICDs [implantable cardioverter defibrillators], and the number of patients having ICD shocks every month is quite substantial,' he said. 'If they all went to Harefield for assessment, that would swamp their services.' Jenkins stressed the importance of identifying the right patients at the right time, which meant finding the 'sweet spot' for patient referral. 'That's what we're not doing well,' he said. LVADs Offer Alternative Solution Separately, Dar told Medscape News UK that while there may not be enough hearts to match presumed demand, modern LVADs were 'almost as good' an alternative. LVADs are mechanical pumps that support circulation in patients with severely weakened hearts. They can be used for long-term support or as a bridge to transplant. Theoretically there were 'unlimited amounts of LVADs', Dar said. As these were 'off-the shelf' items, the waiting time should be shorter than for an appropriate organ donation. Many patients already had access to other advanced treatments like ICDs and cardiac resynchronisation therapies (CRTs), he added. 'The only option they have is an operation that can allow them to live another 8 years.' He emphasised the benefits for younger patients: 'That's giving them back quality life, where they can work again, exercise and do things again – going from being bed bound and possibly dying within a year.' High Mortality in Advanced Heart Failure Dar said advanced heart failure carries significant mortality risk. One-year mortality is around 40% using European Society of Cardiology (ESC) criteria, and 20% with American Heart Association benchmarks. Based on US data, around 14% of a population of around 60,000 met ESC criteria for advanced heart failure, with 5% 'within transplantable age' from 18 to 65, said Dar. Extrapolated to the UK with a total population of 68 million, one million would have a diagnosis of heart failure, 140,000 would have advanced disease, 50,000 would be under 65, and 10,000 eligible for transplantation or LVAD therapy. A 'feeling that we were not getting enough referrals' had led Dar and other transplant physicians across the UK and Ireland to form a working group to look into the issue. The aim was to create a heatmap of referrals that had been made to heart transplant and LVAD centres and assess inequality and equity of care. Audit Exposes Regional Inequalities The working group audited four months of referral data, including 416 patients with a median age of 52. Most were men (67%) and White (73%), with a non-ischaemic cause of heart failure (55%). In 44% of outpatient referrals and 17% of inpatient referrals, patients were considered 'too well' for transplant or LVAD. Respectively, 29% and 39% had contraindications to either option, with 19% and 31% progressing towards a transplant or device fitting. High body mass index was a key exclusion factor, alongside liver or kidney failure, diabetes-related organ damage, or smoking. The audit found significant regional variation – a 'postcode lottery' in access. 'There are large areas, particularly in Wales and the Northeast of England, that are simply not referring patients with advanced heart failure – for transplant or LVAD therapy,' Dar noted. Even areas around specialist transplant centres were not referring patients, he added. Calls for a National Referral Pathway 'It's affirmed what we suspected,' Dar told Medscape News UK . 'So, I think the idea now is to speak to NHS England and colleagues to try and address this inequality and raise awareness of it to see how we can improve things.' One approach, he suggested, might be to create a national pathway that sets out how quickly someone with suspected advanced heart failure was seen by a specialist team. Jenkins observed that travelling to specialist centres could be a problem for many patients living in more rural areas who could face long journeys. He suggested that specialists could perhaps hold monthly clinics withing existing heart failure centres. Whatever the reason for the lack of referrals, Dar said it was clear that more needed to be done: 'We're failing these patients. Speak to your local transplant centres about your patients and just have that conversation early on.' D ar and Jenkins declared no relevant financial relationships
